Search - tctmd.com

Displaying 261 - 280 of 595

Sort: Relevancy | Date

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

News Conference News NY Valves 2024

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Todd Neale

June 11, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Presentation NY Valves 2024

When to Consider TAVR Explant Or Redo ADR Surgery

Presenter: Michael A. Borger

June 07, 2024

Presentation NY Valves 2024

CT Interrogation & Procedure Simulations of Failing Surgical Valves

Presenter: Vinod H. Thourani

June 07, 2024

Presentation NY Valves 2024

TAVR-in-TAVR: Ready for Primetime?

Presenter: Mathew Williams

June 07, 2024

Presentation NY Valves 2024

Valve Fracturing During Surgical Valve-in-Valve Procedures

Presenter: Keith B. Allen

June 07, 2024

Presentation NY Valves 2024

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

When to Consider the Ross and Mitral Reconstruction?

Presenter: Ismail El-Hamamsy

June 07, 2024

Double Valve Reconstruction – Keys to Success

Presentation NY Valves 2024

Double Valve Surgery– Keys to Success

Presenter: Percy Boateng

June 07, 2024

Presentation NY Valves 2024

Mitral Valve Reconstruction in Connective Tissue Syndromes

Presenter: Ahmed El-Eshmawi

June 07, 2024

Presentation NY Valves 2024

Understanding the Genetics and Classification of Connective Tissue Syndromes

Presenter: Amy Kontorovich

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

Presenter: Nino Mihatov

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Advertisement

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

When to Consider TAVR Explant Or Redo ADR Surgery

CT Interrogation & Procedure Simulations of Failing Surgical Valves

TAVR-in-TAVR: Ready for Primetime?

Valve Fracturing During Surgical Valve-in-Valve Procedures

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

When to Consider the Ross and Mitral Reconstruction?

Double Valve Surgery– Keys to Success

Mitral Valve Reconstruction in Connective Tissue Syndromes

Understanding the Genetics and Classification of Connective Tissue Syndromes

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content